Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Domenico Accili
Columbia University Health Sciences, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Forkhead Biotherapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Accili is co-founder of a new startup company called Forkhead Biotherapeutics, and holds equity in this non-public company. Columbia has determined that the company’s aims (developing specific FOXO inhibitors as an oral treatment for diabetes) are related to the research in this F30; that the outcome of this research could affect the company or Dr. Accili’s significant financial interest in the company; and that the design, conduct, and/or reporting of this research could be affected by this financial interest.
Characterizing the Dedifferentiating Beta Cell in Diabetes
PROJECT NARRATIVE Nearly ten percent of the world's adults have diabetes, hence the dire need for therapies that prevent clinical progression of the disease.1 The studies outlined here aim to define the role of a candidate gene, cytochrome b5 reductase 3 (Cyb5r3), in the pathogenesis of beta cell failure. A better understanding of the mechanisms leading to beta cell failure, especially beta cell dedifferentiation, will be essential to the development of novel therapeutic strategies for type I and type II diabetes.
Filed on December 18, 2018.
Tell us what you know about Domenico Accili's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Domenico Accili”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | Value cannot be readily determined |
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | Value cannot be readily determined |
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | Value cannot be readily determined |
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | $0 - $4,999 |
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | $0 - $4,999 |
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | Value cannot be readily determined |
| Domenico Accili | Columbia University Health Sciences | Conflict of Interest | Forkhead Biotherapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.